StockGuru Blog: IncreMental Advantage Initiates Coverage of The Immune Response Corporation – Price Target of $0.09 Per Share Accumulate Rating
IMNR - The Immune Response Corporation IncreMental Advantage, an equity research firm, has initiated coverage of The Immune Response Corporation…